ACE and Parkinson disease: Lastly, a meta-analysis showed that while angiotensin converting enzyme (ACE) inhibitors (ACEI), and angiotensin II receptor blockers (ARBs) did not have an effect on incident PD, calcium channel blockers (CCBs) showed a reduced incidence with a modest effect size [47].